Cargando…
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?
Risk assessment tools are essential in COPD care to help clinicians identify patients at higher risk of accelerated lung function decline, respiratory exacerbations, hospitalizations, and death. RECENT FINDINGS: Conventional methods of assessing risk have focused on spirometry, patient-reported symp...
Autores principales: | Wang, Jennifer M., Han, MeiLan K., Labaki, Wassim W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799486/ https://www.ncbi.nlm.nih.gov/pubmed/34652295 http://dx.doi.org/10.1097/MCP.0000000000000833 |
Ejemplares similares
-
Chronic obstructive pulmonary disease and COVID-19: interrelationships
por: Singh, Dave, et al.
Publicado: (2022) -
Telehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic
por: Sculley, Jennifer A., et al.
Publicado: (2022) -
Do police officers and firefighters have a higher risk of disease than other public officers? A 13-year nationwide cohort study in South Korea
por: Han, Minkyung, et al.
Publicado: (2018) -
Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease
por: Han, Meilan K, et al.
Publicado: (2020) -
IMPACT OF INHALED CORTICOSTEROID USE ON OUTCOMES IN HOSPITALIZED PATIENTS WITH COVID-19 AND OBSTRUCTIVE LUNG DISEASES
por: MARLIERE, MANUEL HACHE, et al.
Publicado: (2022)